Protagonist's Profit Shift: A One Term Solution? Protagonist Therapeutics has reported a remarkable swing from a $34. 8 million loss to a $162.
8 million profit in just one quarter, primarily driven by milestone payments tied to two drugs nearing blockbuster status.
The Blockbuster Factor ICOTYDE and rusfertide are the key drivers behind Protagonist's shift from red ink to black.